Early Changes in SD-OCT After Intravitreal Aflibercept in Patients With nAMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Assessment of Early Changes in Spectral Domain-Optical Coherence Tomography After Initiation of Treatment With Intravitreal Aflibercept (Eylea) Over a 12-Week Period for Patients With Neovascular Age-Related Macular Degeneration: A Multicenter French Study (START)
Retina (Philadelphia, Pa.) 2021 Mar 01;41(3)588-594, JF Korobelnik, EH Souied, H Oubraham, S Razavi, M Mauget-Faÿsse, H Savel, G Chene, S WolfFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.